| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.6 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |